1. Home
  2. LMB vs OBIO Comparison

LMB vs OBIO Comparison

Compare LMB & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Limbach Holdings Inc.

LMB

Limbach Holdings Inc.

N/A

Current Price

$57.02

Market Cap

579.3M

ML Signal

N/A

OBIO

Orchestra BioMed Holdings Inc.

N/A

Current Price

$5.94

Market Cap

473.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LMB
OBIO
Founded
1901
2017
Country
United States
United States
Employees
1400
86
Industry
Engineering & Construction
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
579.3M
473.0M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
LMB
OBIO
Price
$57.02
$5.94
Analyst Decision
Buy
Strong Buy
Analyst Count
5
7
Target Price
★ $76.00
$12.43
AVG Volume (30 Days)
177.6K
★ 410.5K
Earning Date
11-03-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
25.68
★ 33.13
EPS
★ 1.54
N/A
Revenue
★ $646,804,000.00
$33,482,000.00
Revenue This Year
$22.56
N/A
Revenue Next Year
$19.28
$40.42
P/E Ratio
$37.47
★ N/A
Revenue Growth
24.68
★ 1169.22
52 Week Low
$40.74
$3.46
52 Week High
$114.95
$6.50

Technical Indicators

Market Signals
Indicator
LMB
OBIO
Relative Strength Index (RSI) 61.02 54.73
Support Level $47.02 $5.54
Resistance Level $58.99 $6.49
Average True Range (ATR) 2.85 0.40
MACD 0.86 0.02
Stochastic Oscillator 83.74 70.97

Price Performance

Historical Comparison
LMB
OBIO

About LMB Limbach Holdings Inc.

Limbach Holdings Inc is a building systems solutions firm that designs, delivers, and maintains mechanical (heating, ventilation, and air conditioning), electrical, plumbing, and controls (MEPC) systems. The Company partners with owners and operators of facilities across healthcare, industrial and manufacturing, data centers, life sciences, higher education, and cultural and entertainment markets. It operates through two segments: Owner Direct Relationships (ODR), which generates maximum revenue and includes owner direct projects, maintenance, and service on MEPC systems; and General Contractor Relationships (GCR), which manages new construction or renovation projects involving MEPC systems awarded by general contractors or construction managers.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

Share on Social Networks: